United States · Venture startup
3 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$196Mraised across 3 rounds since 2008, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $22M sold, first sale Dec 2013
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
OncoMed Pharmaceuticals's investors include U.S. Venture Partners, Morgenthaler Ventures, Adams Street Partners, Bay Partners and Delphi Ventures, and 4 more on record.
OncoMed Pharmaceuticals has raised $196M across 3 rounds since 2008.
OncoMed Pharmaceuticals's most recent round was a Venture of $22M in Dec 2013.
OncoMed Pharmaceuticals's largest round on record is $154M (Series B), in Nov 2008.
OncoMed Pharmaceuticals's first round on record, in Nov 2008, was backed by U.S. Venture Partners, Morgenthaler Ventures and Adams Street Partners and 6 others.
OncoMed Pharmaceuticals's latest named round is a Venture, in Dec 2013.
OncoMed Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
